Bone Growth Stimulators Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Bone Growth Stimulation Devices (Pulsed Electromagnetic Field Devices, Combined Magnetic Field Devices, Capacitive Coupling Devices, Implanted Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators), Bone Morphogenetic Proteins, Platelet-Rich Plasma), By Application (Spinal Fusion Surgeries, Nonunion Fractures, Oral and Maxillofacial Surgeries, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Homecare, Others), and Region

Bone Growth Stimulators Market size was valued at US$ 1.85 billion in 2023 and is poised to grow at a significant CAGR of 4.7% from 2024-2030. Bone growth stimulation (BGS) is a therapy your surgeon may prescribe following a spinal fusion procedure. A bone growth stimulator is a supplemental device worn following cervical (neck) or lumbar (low back) spine surgery. BGS may be utilized to help spinal bone fuse after a fusion procedure or as a treatment for failed fusion. Due to a sharp drop in elective surgeries, a ban on organised sports, the temporary closure of O&P clinics, hospital access restricted to non-essential care, limited access to clinics, and slowed in-patient flow and referrals, the pandemic is expected to have a short-term negative impact.

The market is expected to gradually rise starting in the late second half of 2021, which could be attributed to addressing pre-COVID elective surgeries, an increase in the number of surgeries as a result of clearing backlogs as well as new cases, fully reopened healthcare services, large-scale recreation and physical work, and the reopening of organised sports. Long-term growth drivers such as the growing senior population and the rising prevalence of diabetes, obesity, and osteoarthritis will also continue to fuel the market's expansion over the forecast period.